Cizzle Bio Partners with Top Institutes for Lung Cancer Detection Research Grant Submission Cizzle Bio has submitted an NIH grant proposal in collaboration with leading research institutions to validate its CIZ1B biomarker blood test for early lung cancer detection.

Cizzle Bio Partners with Top Institutes for Lung Cancer Detection Research Grant Submission #United_States #San_Antonio #Lung_Cancer #Cizzle_Bio #CIZ1B

Cizzle Bio's CIZ1B Test Could Save Medicare $518 Million Annually Thanks to Early Lung Cancer Detection Cizzle Bio's innovative CIZ1B biomarker test for lung cancer could potentially save Medicare up to $518 million each year by enhancing early detection rates.

Cizzle Bio's CIZ1B Test Could Save Medicare $518 Million Annually Thanks to Early Lung Cancer Detection #United_States #Chicago #Lung_Cancer #Cizzle_Bio #CIZ1B

@oncodaily.bsky.social
#CizzleBio #iGenomeDX #Biotech #CIZ1B #EarlyDetection #LungCancerTest